IQE PLC

Director's Dealing • Nov 10, 2023

National Storage Mechanism | Additional information

RNS Number : 9900S

IQE PLC

10 November 2023

IQE plc

Cardiff, UK

10 November 2023

Director/PDMR Shareholding

IQE plc (AIM:  IQE, "IQE", the "Company" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 9 November 2023 that on that date Mr Americo Lemos, Chief Executive Officer of the Group, purchased 1,367,012 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 17.15p.

Following the purchase, Mr Lemos' beneficial interest in the Company has increased to 9,837,469 Ordinary Shares, representing approximately 1.02 percent of the total issued share capital.

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")
a)	Name	Mr Americo Lemos
2.	Reason for the notification
a)	Position / status	Chief Executive Officer
b)	Initial notification / amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IQE plc
b)	Legal Entity Identifier	213800Y33WHD3ESJJP16
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of 1 pence each in the Company GB0009619924
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	1,367,012 Ordinary Shares at a price of 17.15p per Ordinary Share
d)	Aggregated information ·       Aggregated volume ·       Aggregated price	See above
e)	Date of the transaction(s)	9 November 2023
f)	Place of the transaction	London Stock Exchange, AIM (AIMX)

Contacts:

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Neil Rummings

Amy Barlow

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

Richard Chambers

Kate Bannatyne

James Smith

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

Headland Consultancy (Financial PR)

+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHNKCBQQBDDADK